Vetter Pharma-Fertigung GmbH & Co. has been granted approval by the Food and Drug Administration for the production of a new client drug. Vetter, which provides contract manufacturing services for pharmaceutical and biotech companies, will now begin filling an innovative drug at its Ravensburg Vetter South (RVS) facility. The latest FDA client product approval underscores the competence of the world leader in aseptically pre-filled injection systems used in the production of biotechnological and complex medications.
"For us, the approval by the Food and Drug Administration is a vital step in our corporate development," said Thomas Otto, Vetter's Managing Director. "It means that we can continue expanding our business. It also secures our jobs, our investments and our future projects. In addition, it reinforces our position as an expert in the filling of sensitive substances." Vetter currently has a staff of about 1,900. The company works for numerous international pharmaceutical and biotech firms. Vetter has already passed several FDA inspections with excellent marks.
About Vetter Pharma-Fertigung GmbH & Co. KG
Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. Based in Ravensburg, Germany, Vetter also produces its own injection systems, such as the Vetter Lyo-Ject® dual-chamber syringe. With about 1,900 employees worldwide, Vetter holds nearly 140 patents and has longstanding experience in handling client products and processes approved by the FDA, the EMEA and other authorities. In 2007 the company also received the go-ahead as a foreign manufacturer for the Japanese pharmaceutical market from Japan's Ministry for Health, Labor and Welfare. Additionally, Vetter has received two awards for its new facility Ravensburg Vetter South (RVS): The Facility of the Year Award 2007 (Process Innovation category) and the European Outsourcing Award 2007 (Most Improved Process/Plant/Facility category).
Vetter Development Service provides support for its pharmaceutical and biotech clients in the early stages of development, from clinical phases and regulatory approval to worldwide product launch. Vetter Commercial Manufacturing handles the entire production process, from compounding and aseptic filling to the final packaging of a product. Vetter Solutions' patented application systems enable clients to compete more effectively throughout the world.
Source: Vetter Pharma-Fertigung GmbH & Co. KG